Exploratory platform trial to evaluate immunotherapy combinations with chemotherapy for the treatment of patients with previously untreated metastatic pancreatic adenocarcinoma (REVOLUTION) Meeting Abstract
| Authors: | Lyman, J.; O'Reilly, E.; Wainberg, Z.; Fisher, G.; Wolff, R.; Ko, A.; O'Hara, M.; Singh, H.; Amaravadi, R.; Kimmelman, A.; Collison, E.; Khalil, D.; Schmidberger, R.; Cabanski, C.; Maddock, S.; Spasic, M.; Maurer, D.; Da Silva, D.; Perry, C.; Yu, J. X.; Padrón, L.; Bucktrout, S.; Butterfield, L.; Ibrahim, R.; Fairchild, J.; LaVallee, T.; Lillie, T.; Hoos, W.; Boffo, S.; Dugan, L.; O'Donnell-Tormey, J.; Vonderheide, R. |
| Abstract Title: | Exploratory platform trial to evaluate immunotherapy combinations with chemotherapy for the treatment of patients with previously untreated metastatic pancreatic adenocarcinoma (REVOLUTION) |
| Meeting Title: | 37th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2022) |
| Keywords: | nivolumab |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 10 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Nov 8-12 |
| Meeting Location: | Boston, MA |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2022-11-01 |
| Start Page: | A687 |
| Language: | English |
| ACCESSION: | WOS:000919423400616 |
| DOI: | 10.1136/jitc-2022-SITC2022.0656 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 656 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
